Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Sucampo submits lubiprostone NDA

April 5, 2005

Researchers at Janssen describe agents for gastrointestinal disorders

April 1, 2005

Baraclude receives FDA approval

March 31, 2005

AZD-0865 effectively blocks acid output in preclinical tests

March 31, 2005

Arius' ARH-460-16-2 antibody to be studied for IBD

March 31, 2005

XenoPort advances XP-19986 into phase I trials

March 31, 2005

Protein Design Labs plots Nuvion development pathway

March 30, 2005

U.K. clearance for phase III study of COLAL-PRED for acute ulcerative colitis

March 29, 2005

Roche studies Pegasys and Copegus to treat HCV in liver transplant patients

March 24, 2005

New data presented on the PK profile of alvimopan and DA-6034 at the ASCPT

March 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...